Navigation Links
22nd Congress of the European College of Neuropsychopharmacology

The 22nd Congress of the European College of Neuropsychopharmacology (ECNP) will be held from 12-16 September 2009 in Istanbul, Turkey.

More than 6,500 clinical and basic scientists such as psychiatrists, neurologists, psychologists and neuroscience researchers from all over the world will attend the ECNP Congress, which is the largest annual high scientific standard congress on mental disorders and neuropsychopharmacology in Europe. Renowned experts from 25 countries will present the latest achievements and breakthroughs in neuropsychopharmacology and related disciplines in both clinical and preclinical settings, as well as discuss the various aspects of pharmacotherapy of brain disorders and their impact on patients quality of life.

The scientific programme will comprise, among others, the following topics:

  • The future of schizophrenia
  • The role of genetic factors in adult ADHD
  • Is the monoamines involved in shaping conduct disorder?
  • Vaccination for Alzheimers disease in dementia
  • Novel treatment for smoking
  • Maternal serotonin
  • Deep Brain Stimulation: new perspectives for treatment
  • News on the NewMood project

Furthermore, the educational update sessions at the congress will deal with the current knowledge on GABA and biomarkers in neuropsychopharmacology, treatment of insomnia, bipolar disorders and schizophrenia, and the new classification systems ICD-11 and DSM-V.


Contact: Sonja Mak
European College of Neuropsychopharmacology

Page: 1

Related biology news :

1. USGS Coalition to host congressional reception
2. 20th ECNP Congress 2007, Oct. 13-17, Vienna, Austria
3. IEEE-USA commends president for asking Congress to double support for critical research
4. 5th Annual World Health Care Congress April 21-23, Washington, D.C.
5. The 12th International Behavioral Ecology Congress held at Cornell University, Aug. 10-14
6. Ecology, economics and soil societies brief Congress on post-wildfire resource management
7. INCF organizes the first congress dedicated to the emerging field of neuroinformatics
8. IOF World Congress on Osteoporosis in Bangkok to address Asian issues
9. Take advantage of reduced pre-registration rates for the IOF World Congress on Osteoporosis
10. Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok
11. Less than one month to opening of world’s largest global congress on osteoporosis
Post Your Comments:
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016 Houston Methodist Willowbrook ... Cy-Fair Sports Association to serve as their official ... Houston Methodist Willowbrook will provide sponsorship support, athletic ... with association coaches, volunteers, athletes and families. ... Cy-Fair Sports Association and to bring Houston Methodist ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology: